Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atoderm SOS spray for itch relief in childhood eczema
NCT04986384Completed
- Start
- Jan 2019
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Randomised, open-label trial of Bioderma Atoderm SOS spray in atopic dermatitis (AD) (2 arms). Primary endpoints: SCORing Atopic Dermatitis at 4 weeks, Patient Oriented Eczema Measure at 4 weeks and 3 more. Started Jan 2019; status: completed.
02
Drugs
Bioderma Atoderm SOS spray
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04986384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04986384.